{
  "docId": "019de075-7539-774f-abd7-26734f481c17",
  "docSlug": "efb32a48c20b71d9dd70ea37e2f1bc4b",
  "documentTitle": "argenx SE | Investor Presentation Deck | 26 slides",
  "authorId": "argenx-se",
  "authorName": "argenx",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 6,
  "pageCount": 26,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "key_messages",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 2,
  "notes": "The slide uses a hub-and-spoke visual arrangement with a central image of a patient.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-7539-774f-abd7-26734f481c17/6",
  "deckHref": "/decks/019de075-7539-774f-abd7-26734f481c17",
  "deckJsonHref": "/decks/019de075-7539-774f-abd7-26734f481c17.json",
  "deckAnchorHref": "/decks/019de075-7539-774f-abd7-26734f481c17#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.35,
        "w": 0.52,
        "x": 0.24,
        "y": 0.38
      },
      "kind": "image",
      "text": "Patient image",
      "attrs": null,
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0294a89e-4e1b-4cb2-a2b2-0649a1e9f9fb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.16,
        "x": 0.65,
        "y": 0.16
      },
      "kind": "list",
      "text": "Choice in HOW to be Treated: IV infusion or SC injection",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "06be3b52-95f6-4743-a533-49bfffc35db2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.18,
        "x": 0.18,
        "y": 0.16
      },
      "kind": "list",
      "text": "Predictable Safety and Tolerability: 18 months and over 3000* real world patients",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "59fddcbf-2857-40d3-a41f-e04f19fa36f1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.18,
        "x": 0.04,
        "y": 0.48
      },
      "kind": "list",
      "text": "Demonstrated Efficacy: 78% responders across first two treatment cycles in ADAPT",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cc71b4a5-4974-4955-899c-193861eee93f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.16,
        "x": 0.42,
        "y": 0.13
      },
      "kind": "list",
      "text": "Simple Treatment Initiation: broad access, no vaccination requirements",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d11d256a-0ffd-42ca-9ad6-0f04be483edd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.16,
        "x": 0.82,
        "y": 0.48
      },
      "kind": "list",
      "text": "Options for Site of Care: infusion center, HCP office, home administration",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fe513ef3-1dd0-4fb4-afe5-4eed565b1b56",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.08,
        "x": 0.01,
        "y": 0.97
      },
      "kind": "source-note",
      "text": "* As of end of 2022",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6987e424-607b-4a5c-8d93-ce395f2cd6c9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.74,
        "x": 0.13,
        "y": 0.085
      },
      "kind": "title",
      "text": "Lowering the bar for VYVGART treatment initiation and expanding access to gMG patients",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "04529fed-71c2-44da-88b1-51051fd848e5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.78,
        "x": 0.03,
        "y": 0.05
      },
      "kind": "title",
      "text": "VYVGART Simplifies Treatment of gMG in the Community",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "649a61a7-de4b-44ec-a50e-06df662018ab",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Action Titles",
      "slug": "action-titles",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "3fb5558f-4d0e-4fec-b187-f1627cfed4d8",
      "evidence": "The slide has an action title 'Lowering the bar for VYVGART treatment initiation and expanding access to gMG patients'",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "hub-spoke",
      "slug": null,
      "matchId": "067e8a95-9ccf-4baf-9606-69cbdc603034",
      "evidence": "Central image surrounded by benefit bubbles",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 10,
      "from": 6,
      "beatId": "11df2160-3e69-4fb0-a01d-c12161d32bad",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "What",
      "beatSlug": "golden-circle-what",
      "evidence": "Slides 6-10 describe VYVGART and its benefits for patients with Generalized Myasthenia Gravis.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 10,
      "from": 6,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "5a9162d2-2912-4933-9e05-dd879960544e",
      "evidence": "The document emphasizes the complexity and burden of existing treatments.",
      "position": 0,
      "objective": "Highlighting the need for improved treatment options for autoimmunity patients",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}